Status:
UNKNOWN
Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Cholangiocarcinoma
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this protocol is to establish a multicenter registry to evaluate the impact of radiofrequency ablation in the management of patients with pancreatico-biliary disorders including malig...
Detailed Description
Bile duct cancer and pancreatic cancer are cancers that cannot be surgically removed. As the cancer grows, it blocks the drainage of the bile ducts that carry digestive juices from the gall bladder an...
Eligibility Criteria
Inclusion
- Patients who have undergone RFA for pancreaticobiliary disorders
- Above 18 years of age
Exclusion
- Patients who have not undergone RFA
- Below 18 years of age
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01439698
Start Date
September 1 2011
End Date
December 30 2018
Last Update
February 20 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Weill Cornell Medical College
New York, New York, United States, 10021